Press Releases
🇪🇺 EMA Page 7EMA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Access critical pharma & biotech press releases. Stay ahead on drug approvals, clinical trials, M&A, and regulatory updates impacting global markets.
Showing 73–84 of 121 articles
Roche's Gazyva Receives FDA Acceptance for Lupus Treatment Following Positive Phase III Trial Results
Ipsen Receives EU Approval for Ojemda (Tovorafenib) to Treat Pediatric Brain Cancer with BRAF Mutations
RedHill's Opaganib Shows Promise in Neuroblastoma and Triple-Negative Breast Cancer Studies at AACR 2026
SAB Biotherapeutics SAB-142 Shows C-Peptide Preservation in Type 1 Diabetes Phase 1 Trial
Boston Scientific Reports Strong Q1 2026 Growth with 10.9% US Sales Increase and Clinical Trial Breakthroughs
CervoMed's Neflamapimod Shows Brain Volume Increase in Dementia with Lewy Bodies Trial at AAN 2026
Celerion Secures Majority Investment from THL Partners to Expand Clinical Research Services
Veristat Acquires Certara's Regulatory Writing Business to Expand European Market Services
Lung Cancer Therapeutics Market to Hit $142.3 Billion by 2036 as Precision Medicine Drives 11.8% Growth
Drug Delivery Devices Market Poised for Significant Growth Through 2032 Driven by Biologics and Regulatory Support
Polycythemia Vera Market Transformation: 9 Companies Including Protagonist Therapeutics with Rusfertide to Enter by 2036
European Research Revolution: Clinical Trial Tech Focus